Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07883876Not yet recruiting
Randomised, single-blind trial of tenoxicam in Lateral Epicondylitis (LET) (2 arms), sponsored by Ankara Etlik City Hospital. Primary endpoint: Visual Analog Scale at 12 weeks. Planned start Oct 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07883876.